Delivery Order SPE2DB22D1202-SPE2DB25FVFT6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,012.32 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes (0.5 mL units). This is a firm fixed-price delivery order with no set-aside designation, executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,811.29 delivery order contract is for the supply of Phytonadione 10 mg/mL ampoules, a type of injectable vitamin K medication. The contract is not set aside and is a firm fixed-price agreement with a performance period through June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Phytonadione 1 mg/0.5 mL syrup, a Vitamin K medication, with a ceiling value of $11,567.66 and a performance period ending on August 27, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen, through its corporate office division, is the prime...
- This federal contract award is for the delivery of phytonadione (vitamin K1) 1 mg/0.5 mL syrup in 0.5 mL vials to the Defense Logistics Agency (DLA). The $1,836.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 15, 2023, with a completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,608.38 firm fixed-price contract is for the supply of Phytonadione 1 mg/0.5 mL Syrup, a medication used to treat Vitamin K deficiency. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $16,762 to Amerisourcebergen Drug Corporation to supply 4561665618 phytonadione 10 mg/ml ampules. The single award was issued against an indefinite delivery/indefinite quantity contract held by Amerisourcebergen Corporation for pharmaceutical products and services. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August to fulfill the...
- This federal contract award, valued at $4,415.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phytonadione 1 mg/0.5 ml syrup, a medication used for the treatment of vitamin K deficiency. The contract is structured as a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 21, 2022. This award is not...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFT6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in military and federal healthcare systems for blood clotting disorders and anticoagulation management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's demonstrated capability in fulfilling federal procurement requirements through open competition positions it as a critical vendor within the DLA Medical Supply Chain infrastructure supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 7/28/25 |